{"raw_mentions": "There are no sentences that meet the specified criteria, as none of the sentences contain a bioactivity metric (e.g., IC50, Ki, Kd, EC50, pIC50, pEC50, pKi, pKd) with a specific numeric value and unit. The text primarily discusses dosages and administration schedules for various kinase inhibitors, but does not provide bioactivity data."}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nIn embodiments, idelalisib is administered at a dosage of about 100-400 mg (e.g., 100-125, 125-150, 150-175, 175-200, 200-225, 225-250, 250-275, 275-300, 325-350, 350-375, or 375-400 mg), e.g., BID.\nIn embodiments, duvelisib is administered at a dosage of about 15-100 mg (e.g., about 15-25, 25-50, 50-75, or 75-100 mg), e.g., twice a day.\nIn embodiments, rituximab is administered at a dosage of about 350-550 mg/m<sup>2 </sup>(e.g., 350-375, 375-400, 400-425, 425-450, 450-475, or 475-500 mg/m<sup>2</sup>), e.g., intravenously."}
{"final_json": [{"molecule_name": "idelalisib", "protein_target_name": null, "binding_metric": null, "value": "100-400", "unit": "mg", "is_logarithmic": false}, {"molecule_name": "duvelisib", "protein_target_name": null, "binding_metric": null, "value": "15-100", "unit": "mg", "is_logarithmic": false}, {"molecule_name": "rituximab", "protein_target_name": null, "binding_metric": null, "value": "350-550", "unit": "mg/m^2", "is_logarithmic": false}]}
